---
title: "MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287761687.md"
description: "The Phase III VALUE trial for EscharEx® is progressing, with an interim assessment and completion of enrollment anticipated by the end of the first quarter of 2027. This trial is a crucial stage in testing the effectiveness and safety of EscharEx®, with significant milestones expected to be reached in the near future. Stay tuned for updates on this important development in the medical field."
datetime: "2026-05-27T11:02:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287761687.md)
  - [en](https://longbridge.com/en/news/287761687.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287761687.md)
---

# MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update

The Phase III VALUE trial for EscharEx® is progressing, with an interim assessment and completion of enrollment anticipated by the end of the first quarter of 2027. This trial is a crucial stage in testing the effectiveness and safety of EscharEx®, with significant milestones expected to be reached in the near future. Stay tuned for updates on this important development in the medical field.

### Related Stocks

- [MDWD.US](https://longbridge.com/en/quote/MDWD.US.md)

## Related News & Research

- [19:17 ETProteotype Unveils Alchemi®, the Data and Orchestration Platform Behind Enlighten®](https://longbridge.com/en/news/294426611.md)
- [AgroGalaxy delays release of 2025 results to Aug. 31](https://longbridge.com/en/news/294505926.md)
- [Eversource (ES) Stock Could Be Fully Priced As Aquarion Sale Reshapes Focus](https://longbridge.com/en/news/294574756.md)
- [Dexxos Participações Notifies Market of Press Release Availability](https://longbridge.com/en/news/294065346.md)
- [Contax Participações updates financial reporting and AGM calendar for 2026](https://longbridge.com/en/news/294556417.md)